Anru Zhang, PhD, hopes to give physicians another tool to treat disease and improve health – by turning patients’ electronic medical records into a treasure trove of information.

Cynthia Toth, MD, has revolutionized retinal imaging for both adult and pediatric patients. A pioneer and one of the world’s leading experts in optical coherence tomography (OCT), she has helped develop better ways to diagnose and predict the course of blinding eye diseases such as macular degeneration and retinopathy of prematurity, one of the most common causes of childhood vision loss.

Duke University cardiology researchers are teaming up with North Carolina emergency care personnel—EMS, fire, police, 911 dispatch and community members—across the state in a pragmatic cluster-randomized trial that will test community interventions to improve survival for out of hospital cardiac arrest, a leading cause of death in the U.S.

The Duke Human Vaccine Institute (DHVI) and the Department of Surgery at Duke University School of Medicine received a grant from the National Institute of Allergy and Infectious Diseases for HIV vaccine research that could total $25.9 million with full funding over five years.

Transcendental Meditation may help improve the lives of health care workers experiencing burnout, poor sleep, and anxiety symptoms.  

Several Duke Cancer representatives were thrilled to join the founders of the I’m Not Done Yet Foundation, an important partner with DCI’s Teen and Young Adult Oncology Program, to ring the opening bell at Nasdaq on Friday, Oct. 7.

Ernest Mario, PhD, and his family, through the Mario Family Foundation, recently made an important new gift that builds upon their past support and will nurture innovation in health care and patient experience for years to come.

Duke Health leadership launched Translating Duke Health in 2017 as a multi-disciplinary, multi-year commitment to capitalize on Duke’s collective strengths in research, clinical care, and popul

Duke University researchers have developed an RNA-based editing tool that targets individual cells, rather than genes. It is capable of precisely targeting any type of cell and selectively adding any protein of interest. Researchers said the tool could enable modifying very specific cells and cell functions to manage disease.

Two Duke professors are among just eight scholars nationwide who have been awarded prestigious Pioneer Awards this year from the National Institutes of Health (NIH).